Publication | Closed Access
Palivizumab for respiratory syncytial virus prophylaxis in high-risk infants: a cost-effectiveness analysis
66
Citations
19
References
2000
Year
VaccinationPreventive MedicineCost-effectiveness AnalysisPediatricsRespiratory InfectionEducationPediatric Lung DiseaseInfectious Respiratory DiseaseHigh-risk InfantsMedicine
| Year | Citations | |
|---|---|---|
Page 1
Page 1